Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Amarin Corp Ads (NQ: AMRN)
16.82 USD  -0.11 (-0.64%)
Streaming Delayed Price  /  Updated: 10:30 AM EDT, Sep 19, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,037,191
Open 17.03
Bid (Size) 16.82 (11)
Ask (Size) 16.83 (2)
Prev. Close 16.93
Today's Range 16.65 - 17.06
52wk Range 2.650 - 23.91
Shares Outstanding 293,584,140
Dividend Yield N/A
Performance
YTD
+29.30%
+29.30%
1 Month
+7.42%
+7.42%
3 Month
-13.74%
-13.74%
6 Month
-11.51%
-11.51%
1 Year
+509.47%
+509.47%
Top News
More News
National Lipid Association’s New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statin
from GlobeNewswire News Releases
New 2019 Updates to the European Society of Cardiology’s and European Atherosclerosis Society’s Guidelines for the Management of Dyslipidaemias Incorporate Findings from the REDUCE-IT™ Cardiovascular
Clinical Practice Guidelines address how best to prevent cardiovascular events in high-risk patients with elevated triglycerides on statin treatment, among millions of people globally Read More
from GlobeNewswire News Releases
More News
Read More
Amarin to Participate in the H.C. Wainwright 21st Annual Global Investment Conference
from GlobeNewswire News Releases
Amarin Provides Overview on Growing Global Attention on REDUCE-IT™ Results and Cardiovascular Risk Management Beyond Cholesterol Management
from GlobeNewswire News Releases
Amarin to Participate in a Fireside Chat at Citi’s 14th Annual Biotech Conference
from GlobeNewswire News Releases
Non-Invasive Cellulite Treatments and Devices Dominating Billion Dollar Market
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Non-Invasive Cellulite Treatments and Devices Dominating Billion Dollar Market
from PR Newswire
Biotech Brief: Latest Electrophysiology Devices Vastly Improving Diagnosis and Treatment of Cardiovascular Diseases
from GlobeNewswire News Releases
Why Amarin Stock Dropped 19% in August
category AMRN , Market News
from Motley Fool
Amarin: Keep Your Dry Powder Ready
category PFE , NVS , AMRN , and 2 more.
from Motley Fool
Jim Cramer Gives His Opinion On Amarin, Owens-Illinois And More
category DCP , OI , AMRN , and 8 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.